Clinical Trials on Ovarian Cancer in Hungary
Total 674 results
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
Peter Kovacs MDRecruitingInfertility | Ovarian DysfunctionHungary
-
Semmelweis UniversityRecruitingObesity | Polycystic Ovary Syndrome | Insulin Resistance | Primary Ovarian Insufficiency | Infertility, Female | Mitochondrial AlterationHungary
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
-
Semmelweis UniversityPharma Patent Kft.SuspendedPolycystic Ovary Syndrome | Vitamin D DeficiencyHungary
-
Oasmia Pharmaceutical ABCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUkraine, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Latvia, Lithuania, Romania, Russian Federation, Serbia, Slovakia, Sweden
-
Ludwig-Maximilians - University of MunichUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerGermany, Netherlands, Hungary
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
BioNumerik Pharmaceuticals, Inc.Crown BioscienceCompletedOvarian CancerPoland, Russian Federation, Romania, Hungary, Lithuania
-
Astellas Pharma IncCompleted
-
Ellipses PharmaCompletedOvarian CancerUnited States, United Kingdom, Hungary
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
National Institute of Oncology, HungaryUnknownInvasive Breast Cancer | in Situ Breast CancerHungary
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
Seagen Inc.GenmabCompletedBladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer (NSCLC)United States, United Kingdom, Belgium, Hungary, Denmark
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
Lightpoint Medical LimitedSemmelweis UniversityWithdrawnGastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenal CancerHungary
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT); Myriad... and other collaboratorsActive, not recruitingAdvanced Ovarian CancerCanada, Denmark, Germany, Italy, Spain, United States, Belgium, Poland, France, Korea, Republic of, Brazil, Hungary, Japan, Peru, Turkey, China, Austria, Bulgaria, Finland, Romania
-
Semmelweis UniversityRecruitingHER2-negative Breast CancerHungary
-
Menarini GroupTerminatedOvarian CancerUnited States, Spain, Germany, Belgium, France, Czech Republic, Hungary, Italy, Poland
-
National Institute of Oncology, HungaryNot yet recruiting
-
Szeged UniversityRecruiting
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient SatisfactionHungary
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryCompleted
-
University of DebrecenUniversity of Pecs; National Institute of Oncology, Hungary; Uzsoki Street Hospital...RecruitingStomach Neoplasms | Stomach Cancer | Gastric Cancer | Digestive System Neoplasm | InterleukinHungary
-
TelikCompletedOvarian NeoplasmsUnited States, Czech Republic, South Africa, Argentina, Belgium, Spain, Brazil, Chile, Germany, Hungary, Ireland, Netherlands, United Kingdom
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
László MangelE-Group ICT Software Informatikai Zrt.RecruitingMetastatic Castration-resistant Prostate Cancer | Adenocarcinoma of the ProstateHungary
-
National Institute of Oncology, HungaryActive, not recruitingBreast Cancer | Radiation Toxicity | Side EffectsHungary
-
PfizerTerminatedOvarian CancerUnited States, Canada, United Kingdom, Korea, Republic of, Netherlands, Hong Kong, Singapore, Ireland, Estonia, Japan, Taiwan, Italy, Turkey, Slovakia, Germany, Poland, Switzerland, Croatia, Hungary, Bulgaria, Latvia, Mexico, Romania, Russian Federation and more
-
Hoffmann-La RocheCompleted
-
Brno University HospitalUniversity Hospital PilsenUnknownOvarian NeoplasmsCzechia, Hungary, Poland, Slovakia, Spain, Ukraine
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
St. Borbala HospitalBiological Research Centre, SzegedSuspendedColorectal CancerHungary
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
SanofiRegeneron PharmaceuticalsCompletedOvarian Neoplasms | AscitesUnited States, Canada, Spain, India, Belgium, Austria, Hungary, Israel, United Kingdom
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
University of PecsHungarian Pancreatic Study Group (HPSG)RecruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Pancreatic Cancer | Diabetes type2 | Pancreas Adenocarcinoma | Cancer of Pancreas | Pancreas NeoplasmHungary
-
University of PecsRecruitingWaiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on OutcomesHungary